Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOLERO-2: Everolimus + Exemestane in Advanced Breast Cancer
NCT00863655Phase 3Completed
- Sponsor
- Novartis
- Start
- Jun 2009
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 24
01
Overview
A Phase 3 trial of everolimus in breast cancer, sponsored by Novartis. Started Jun 2009; status: completed.
02
Drugs
everolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00863655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00863655.